Targeting B-Cell Lymphomas: The Latest Updates in Therapies, Practice Strategies, and Clinical Research
The standards of care in treatment for non-Hodgkin lymphomas (NHL) are evolving as new therapies receive FDA approval and new evidence provides insight into optimal evidence-based approaches. Several key cellular pathways that drive malignant B-cell development have recently been identified and validated, leading to the development of therapies targeting these pathways. Agents targeting the B-cell ...
- Online Presentation
No expired programs found.